Company: EVLVW
Filing Date: 2025-05-15
Form Type: NT 10-Q
Source: 0001104659-25-049608
Chunk: 2

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-05-15
Form: NT 10-Q
Chunk 2
---
2024 contained in its Quarterly Reports on Form 10-Q (collectively,
the “Restatement Periods”) for each of those respective financial periods. Restated consolidated financial statements or
restated financial information for the Restatement Periods were included in the 2024 Form 10-K and Q3 2024 Form 10-Q, as applicable,
each filed on April 28, 2025.

Given the demands on management’s time that
were required to complete and file the 2024 Form 10-K and Q3 2024 Form 10-Q, the Company requires additional time to complete
its financial statements and other disclosures in the Q1 2025 Form 10-Q. The Company expects to file the Q1 2025 Form 10-Q within
the extension period of five calendar days as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”).

<div align='center'>PART IV

OTHER INFORMATION</div>

(1) Name and telephone number of person to
contact in regard to this notification

| Rachel Roy |     |        781 |     | 374-8100          |
| (Name)     |     | -Area Code |     | -Telephone Number |

(2) Have all other periodic reports required
under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer
is no, identify report(s).

xYes¨
No

(3) Is it anticipated that any significant
change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to
be included in the subject report or portion thereof?

xYes¨
No

If so, attach an explanation of the anticipated
change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be
made.

For the quarter ended March 31, 2025, on a preliminary unaudited
basis, the Company expects to recognize between $31.0 million and $32.0 million of total revenue. For the quarter ended March 31, 2024, revenue
was $22.2 million.

For the quarter ended March 31, 2025